Literature DB >> 26051061

Psoriasis inversa: A separate identity or a variant of psoriasis vulgaris?

Silje Haukali Omland1, Robert Gniadecki2.   

Abstract

Psoriasis is a chronic skin disorder affecting approximately 2% of the European and American population. The most common form of psoriasis is the chronic plaque type. Inverse psoriasis, also named flexural or intertriginous psoriasis, is not considered a separate disease entity but rather a special site of involvement of plaque psoriasis, characterized by its localization to inverse/intertriginous/flexural body sites. We review current evidence and establish whether inverse psoriasis is a separate disease entity based on characteristics in terms of epidemiology, pathogenesis, clinical and histologic presentation, microbiology, and treatment.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26051061     DOI: 10.1016/j.clindermatol.2015.04.007

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


  12 in total

Review 1.  Psoriatic arthritis and psoriasis: differential diagnosis.

Authors:  Maddalena Napolitano; Francesco Caso; Raffaele Scarpa; Matteo Megna; Angela Patrì; Nicola Balato; Luisa Costa
Journal:  Clin Rheumatol       Date:  2016-05-07       Impact factor: 2.980

Review 2.  Pain Management in Painful Psoriasis and Psoriatic Arthropathy: Challenging and Intricately Intertwined Issues Involving Several Systems.

Authors:  Vijay Kodumudi; Kanishka Rajput
Journal:  Curr Pain Headache Rep       Date:  2021-04-06

3.  IL-17 Responses Are the Dominant Inflammatory Signal Linking Inverse, Erythrodermic, and Chronic Plaque Psoriasis.

Authors:  Xianying Xing; Yun Liang; Mrinal K Sarkar; Liza Wolterink; William R Swindell; John J Voorhees; Paul W Harms; Joanne M Kahlenberg; Andrew Johnston; Johann E Gudjonsson
Journal:  J Invest Dermatol       Date:  2016-07-21       Impact factor: 8.551

Review 4.  [Intertriginous psoriasis].

Authors:  C Thomas; M Matthies; B Homey; S Meller
Journal:  Hautarzt       Date:  2020-04       Impact factor: 0.751

5.  Inverse psoriasis treated with ustekinumab.

Authors:  Manuel António Campos; Paulo Varela; Armando Baptista; Ana Isabel Moreira
Journal:  BMJ Case Rep       Date:  2016-05-24

6.  Inverse Psoriasis with Autoimmune Hepatitis.

Authors:  Joon Seok; Kui Young Park; Hyun Woong Lee; Hee Sung Kim; Joo Hyun Shim; Seong Jun Seo; Chang Kwun Hong
Journal:  Ann Dermatol       Date:  2017-10-30       Impact factor: 1.444

7.  Development of Drug-Induced Inverse Psoriasis in a Patient with Crohn's Disease.

Authors:  Evan Darwin; Amar Deshpande; Hadar Lev-Tov
Journal:  ACG Case Rep J       Date:  2018-06-20

Review 8.  Tacrolimus for the management of psoriasis: clinical utility and place in therapy.

Authors:  Nina Malecic; Helen Young
Journal:  Psoriasis (Auckl)       Date:  2016-12-07

Review 9.  The Brain-Skin Connection and the Pathogenesis of Psoriasis: A Review with a Focus on the Serotonergic System.

Authors:  Ana M Martins; Andreia Ascenso; Helena M Ribeiro; Joana Marto
Journal:  Cells       Date:  2020-03-26       Impact factor: 6.600

10.  Widespread hyperpigmented rash present for 1 year.

Authors:  Carly Dunn; Danielle S Applebaum; Harry Dao
Journal:  JAAD Case Rep       Date:  2018-09-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.